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Abstract
Introduction
The overall health status of the Omani population has 
evolved over the past 4 decades from one dominated by 
infectious disease to one in which chronic disease poses the 
main challenge. Along with a marked reduction in the inci-
dence of infectious diseases, improvements in health care 
and socioeconomic status have resulted in sharp declines 
in  infant  and  early  childhood  mortality  and  dramatic 
increases in life expectancy. 
Methods
Focusing on the time period from 1990 through 2005, we 
reviewed relevant epidemiological studies and reports and 
examined socioeconomic indicators to assess the impact of 
the changing disease profile on Oman’s economy and its 
health care infrastructure.
Results
Over the next 25 years, the elderly population of Oman 
will increase 6-fold, and the urbanization rate is expected 
to reach 86%. Currently, more than 75% of the disease 
burden in Oman is attributable to noncommunicable dis-
eases, with cardiovascular disease as the leading cause of 
death. The distribution of chronic diseases and related risk 
factors among the general population is similar to that of 
industrialized nations: 12% of the population has diabetes, 
30% is overweight, 20% is obese, 41% has high cholesterol, 
and 21% has the metabolic syndrome. 
Conclusion
Unless reforms are introduced to the current health care 
system, chronic diseases will constitute a major drain on 
Oman’s human and financial resources, threatening the 
advances in health and longevity achieved over the past 
4 decades.
Introduction
The rising burden of noncommunicable diseases (NCDs) 
has been an increasing public health concern globally. In 
2005, the World Health Organization (WHO) estimated 
that  61%  of  deaths  (35  million)  and  49%  of  the  global 
burden of disease were attributable to NCDs (1). Eighty 
percent of such deaths occurred in low- and middle-income 
developing countries where health resources are limited 
(2). If current trends continue, by 2030 chronic diseases 
will account for 70% of total global deaths and 56% of the 
global disease burden (1).
Oman,  located  in  the  southeastern  corner  of  the 
Arabian peninsula, has a land area of 309,000 square 
kilometers.  In  1959,  the  country  emerged  from  sev-
eral  wars  between  tribal  factions  in  the  interior  and 
coastal areas (3). The last conflict, which took place in 
the south, ended in 1982 with the forging of a treaty 
between Oman and Yemen. Since then, the country has 
maintained internal peace and stability and peace with 
its neighbors. In 1970, Sultan Qaboos bin Said assumed 
power and set the country on the path of modernization. 
In less than 20 years, Oman acquired all the attributes 
of a modern state: running water, electricity, telephone, 
television, shopping malls, schools, university education, 
hospitals, and clinics (4).
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Like  many  developing  countries,  Oman  bears  a  high 
burden  of  NCDs.  Several  studies  have  documented  the 
distribution of risk factors associated with NCDs in this 
relatively  small  country  (5-9).  We  describe  the  rapid 
changes in the epidemiologic map of Oman from one domi-
nated by first-generation diseases (i.e., infectious diseases) 
to the emergence of NCDs as the dominant feature of ill 
health. Furthermore, we elaborate on the accompanying 
demographic,  socioeconomic,  and  behavioral  risk  factor 
changes that have contributed to the current epidemio-
logic transition.
Methods
The  Directorate  General  of  Planning  of  the  Omani 
Ministry of Health routinely collects data for health plan-
ning purposes. Data on morbidity, mortality, and use of 
health care services are compiled from primary-, second-
ary-, and tertiary-care regional health institutions by a 
Health Information Unit, headed by a statistician, in each 
of Oman’s 10 administrative regions. These data are fed 
into electronic templates and sent to the central Health 
Information  Unit.  There,  information  is  reviewed  and 
published as an annual health report. We reviewed these 
reports for the years 1990 through 2005.
In  addition,  the  Oman  Ministry  of  Health’s  Research 
Department designs and conducts national health surveys 
every 5 to 10 years to provide decision makers with com-
munity-based data on certain variables, including behav-
ioral and biological risk factors for NCDs. We reviewed the 
report of the Oman National Health Survey 2000 (10), the 
Joint Study Report on Mortality and Health Transitions 
in Oman (3), several WHO consultants’ reports on primary 
care  in  Oman  (11,12),  and  the  1999  World  Bank  Cost-
Effectiveness  Review  of  the  Health  Sector  (13).  We  also 
searched the National Library of Medicine’s MEDLINE 
database for publications on chronic diseases pertinent to 
Oman.
Although the accuracy of the health information data 
gathered by the Directorate General of Planning in the 
Omani Ministry of Health has not been formally assessed, 
health  information  officers  from  various  WHO  member 
states in the Eastern Mediterranean Region (EMR) have 
visited Oman several times to learn from its health infor-
mation  systems.  In  addition,  the  International  Agency 
for Research on Cancer, a specialized WHO agency, has 
examined Oman’s cancer registry data and has considered 
it  sufficiently  reliable  to  be  included  in  its  publication, 
Cancer Incidence in Five Continents (http://www.iacr.com.
fr/statist.htm). Oman is 1 of only 2 countries among the 22 
EMR member states whose cancer data were included.
Results
Demographic and economic profile 
The total population of Oman is estimated to be 2.5 
million, of which 1.8 million are Omani citizens. Nearly 
54% of Omanis are younger than 20 years, and only 3.5% 
are older than 60 years. Life expectancy increased by 25 
years in a period of 35 years, from 49.3 years in 1970 
to  74.3  years  in  2005.  The  current  annual  population 
growth rate is 2.2%. By 2030, the total population will 
double (14). Approximately 70% of the increase will occur 
in the group aged 15 to 64 years. Over the same period, 
the number of Omanis aged 65 and older will increase 
6-fold. Urbanization has risen from 11% in 1970 to 79% 
in 2005 and is projected to reach 86% by 2030 (15). A 
rapidly growing number of Omanis are leaving arable 
land and labor-intensive jobs and moving to the capital 
city of Muscat to work in less strenuous office-based or 
industrial jobs. These changing trends in urbanization 
(i.e., the number of people living in urban areas) and 
employment  lead  inevitably  to  lifestyle  changes  that 
expose the population to increased biological and behav-
ioral risk factors.
Partially as the result of an intense birth control cam-
paign  begun  in  the  1990s,  the  total  birth  rate  among 
women aged 15 to 45 years declined by almost 50% in 
10 years, from 6.0 per woman in 1995 to 3.1 per woman 
in 2005. The World Bank classifies Oman as an upper-
middle–income  developing  country,  and  WHO  stratifies 
it as a country with low child and adult mortality rates. 
The discovery of oil in Oman in 1964 and its commercial 
exploitation in 1967 has led to a steady increase in per 
capita income from U.S. $410 in 1970 to more than U.S. 
$12,000 in 2005.
Control of communicable diseases 
Successful  interventions  have  prevented  or  con-
trolled  communicable  diseases  in  Oman,  among  them, 
the  implementation  of  WHO’s  Expanded  Programme 
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improvements in living con-
ditions  and  basic  sanita-
tion,  and  provision  of  free 
health  care  services  to  all 
citizens.  Immunization  cov-
erage  has  been  maintained 
at  nearly  universal  levels 
(greater  than  95%)  for  all 
vaccine-preventable diseases 
within  the  EPI,  and  polio 
and  diphtheria  have  not 
been reported in the country 
since 1990. These interven-
tions have contributed to the 
rapid  decline  in  mortality 
rates  among  infants  (from 
118/1000 live births in 1970 
to  10.3/1000  live  births  in 
2005) and children under age 5 years (181/1000 in 1970 to 
11.0/1000 in 2005) (Figure 1) (16). 
Within  11  years  (1995–2005),  the  number  of  malaria 
cases in Oman dropped from more than 32,000 to 544. All 
of the 544 cases were classified as imported cases, mostly 
from East Africa and the Indian subcontinent. A signifi-
cant but slower decline has occurred in the total number 
of cases of pulmonary tuberculosis, from 258 cases in 1985 
to 131 cases in 2005 (16).
Rising tide of noncom-
municable diseases 
In  2002,  NCDs  in 
Oman  accounted  for 
more  than  75%  of 
hospital deaths and a 
similar  percentage  of 
disability-adjusted  life 
years (DALYs) lost (1). 
In 2005, 40% of inpa-
tient  and  55%  of  out-
patient morbidity was 
attributed  to  chronic 
diseases,  compared 
with 36% and 43% in 
1995,  an  increase  of 
11% and 28%, respec-
tively (16). In 2002, car-
diovascular  disease  (CVD) 
ranked first among the lead-
ing causes of death (Figure 
2) and third among causes of 
lost DALYs (Figure 3). The 
prevalence  of  hypertension 
(blood pressure ≥140/90 mm 
Hg) among both sexes aged 
20 years or older has risen 
from 27% in 1995 to 32% in 
2000 (6,10).
According to the National 
Health Survey of 2000 (18), 
the  prevalence  of  diabetes 
mellitus in Oman rose from 
8.3%  in  1991  to  11.6%  in 
2000 among adults aged 20 
years or older. The survey, 
which  employed  identical  methodology  and  diagnostic 
criteria for both years (19), showed 7.1% of men and 5.1% 
of women had impaired fasting glucose. Only one-third of 
people with diabetes knew that they had the condition (18). 
WHO estimates a 190% increase in the number of people 
living  with  diabetes  in  Oman  over  the  next  20  years, 
from 75,000 in 2000 to 217,000 in 2025 (20). Omanis also 
have  high  rates  of  diabetes-related  complications.  More 
than 14% of people with diabetes in Oman were found to 
have diabetic retinopathy compared with 11.6% of Saudis 
and 6.7% of Indians 
(21).  Twenty-seven 
percent  of  Omanis 
with  type  2  diabe-
tes  had  microalbu-
minuria (22). More 
than 50% of ampu-
tations  in  Oman 
are  attributed  to 
diabetes  mellitus 
(16).
Data  from  the 
National  Cancer 
Registry  show 
approximately  900 
new cases of cancer 
reported  annually 
in Oman. Malignant 
neoplasms  are  the 
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Figure 1. Trends in mortality among infants and children under age 5 
years, life expectancy at birth, and total fertility rates, Oman 970–2005 
(6). Fertility data for the years 970–980 and 985–995 are not avail-
able. 
Figure 2. Estimated deaths attributable to 
diseases and injuries, all ages, Oman, 2002 
(7). 
Figure 3. Estimated disability-adjusted life 
years lost attributable to diseases and inju-
ries, all ages, Oman, 2002 (7). VOLUME 5: NO. 3
JULY 2008
second leading cause of death and the third cause of lost 
DALYs in Oman. The annual age-adjusted incidence of 
cancer ranges from 70 to 110 per 100,000 population. Non-
Hodgkin’s lymphoma, leukemia, and gastric cancer are the 
most common cancers among men, and breast cancer and 
leukemia are the most common among women. Unlike the 
United States and other parts of the world, lung cancer 
is only the fourth most common malignancy among men, 
likely  because  smoking  was  not  introduced  widely  in 
Oman until after 1970.
High burden of risk factors 
Although pockets of malnutrition still exist (2.2% of chil-
dren under age 5 years have protein-energy malnutrition), 
30%  of  Omani  adults  are  overweight  (body  mass  index 
[BMI] 25.0 to 29.9 kg/m2) and 20% of adults are obese 
(BMI ≥ 30.0 kg/m2) (23). The rate of private car owner-
ship is as high as 69% among Omanis (24). Data on food 
imports (Table) indicate an increasing trend of per capita 
consumption of refined sugar, dried and evaporated whole 
milk,  chicken,  cheese,  and  chocolate  products  over  the 
past decade, while fruit consumption has increased only 
slightly (25).
The prevalence of high cholesterol (total serum choles-
terol >5.2 mmol/L) was 41% in 2000 (10). Another survey 
of adults in the city of Nizwa in 2001 showed that more 
than  35%  of  those  surveyed  had  high  total  cholesterol, 
25% had high triglyceride levels, and 77% had abnormal 
high-density  lipoprotein  (8).  The  same  survey  indicated 
that 21% of adults had metabolic syndrome as defined by 
the National Institutes of Health Adult Treatment Panel 
III (26). Similar rates of metabolic syndrome have been 
reported among the U.S. adult population (27). More than 
28% of adults in Nizwa reported no physical exercise dur-
ing working hours, and 60% did not engage in any leisure 
time physical activity (28).
Data on tobacco use show a 25% increase in per capita 
imports from 1993 to 2003 (Table) (25). Currently, more 
than 13% of Omani adults are smokers, 13.4% of men and 
0.5%  of  women.  In  the  Oman  component  of  the  Global 
Youth Tobacco Survey (GYTS 2003), 27% of boys and 9% of 
girls aged 13 to 15 years were current users of some form 
of tobacco (29). Waterpipe smoking is gaining popularity 
among youth, with 15% of boys and 3% of girls reporting 
this form of smoking in 2003 (30). Curbing tobacco use has 
been an important area of work for the Oman Ministry 
of Health, and Oman is party to the WHO Framework 
Convention on Tobacco Control.
To combat the surge of behavioral risk factors, a com-
munity-based  demonstration  project  aimed  at  reducing 
NCDs and their associated risk factors was established in 
the city of Nizwa in 2001, and a similar project is currently 
underway in the eastern city of Sur. The WHO Healthy 
Cities Program (31) has been under way in the eastern 
region of Kalhat for more than 10 years.
Within the Oman Ministry of Health there is a director-
ate for control of noncommunicable diseases and another 
for  community-based  initiatives,  both  of  which  address 
common chronic conditions such as diabetes. These agen-
cies ensure availability of Arabic-speaking diabetes spe-
cialists in every region of Oman. Small diabetes clinics, 
run by family physicians on specific days of the week, have 
been established in most primary health care (PHC) cen-
ters. Management guidelines to treat diabetes and hyper-
tension have been developed and are updated regularly.
Discussion
The  health  care  system  of  Oman  faces  formidable 
challenges in its efforts to prevent chronic diseases from 
eroding  the  achievements  of  the  past  4  decades.  First, 
increases in the population will lead to an estimated 210% 
increase in the demand for health care by 2025, and treat-
ment of CVD alone will account for 21% of total health care 
expenditures (32). Furthermore, the Omani health system 
currently suffers from overuse of health services, both by 
patients, with 5.6 visits per person per year, and by physi-
cians, with 70% of tests requested being unnecessary (33). 
Second, patients’ expectations for quality of care and bet-
ter health outcomes are increasing; continuing with the 
current modest standards of clinical care may erode the 
public’s confidence in the national health system. Third, 
the current rate of increase in the cost of health care is 
a cause of great concern for sustainability of health care 
services, especially given the rapid rate at which costs are 
increasing.  Although  Oman’s  per  capita  expenditure  on 
health (U.S. $220) is lower than that of neighboring Arab 
Gulf states (U.S. $665 in United Arab Emirates and U.S. 
$539 in Bahrain) (34), health care expenditures increased 
by  64%  from  1995  to  2005.  Clearly,  improving  care  for 
chronic diseases would put incrementally increased finan-
cial demands on an already resource-constrained health 
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care services from acute and episodic treatment to treat-
ment that meets the ongoing needs of people with chronic 
conditions,  with  greater  focus  on  health  promotion  and 
chronic disease prevention.
Despite  the  fact  that  preventive  health  care  services 
were  emphasized  in  every  5-year  plan  of  the  Oman 
Ministry of Health, until recently health care policy mak-
ers  have  focused  on  meeting  public  demand  for  health 
facilities and services by providing curative clinical servic-
es to the newly developing regions of Oman. One positive 
aspect of this has been the availability of secondary-care 
services  in  all  regions  of  Oman.  Another  has  been  the 
rapid expansion of the PHC centers network throughout 
the country. However, the current primary care system is 
still geared more to combating infectious diseases, provid-
ing  immunizations,  and  providing  prenatal  care  rather 
than to meeting needs arising from the growing burden of 
NCDs. Most primary care physicians and nurses are not 
educated beyond their basic training to deal with common 
complex diseases like diabetes, hypertension, asthma, and 
psychiatric conditions. Drugs necessary to treat common 
conditions such as hyperlipidemia (statins), hypertension 
(angiotensin-converting  enzyme  inhibitors),  depression, 
and other common chronic conditions are dispensed not 
in primary care facilities where most people access health 
care, but mostly in secondary and tertiary care facilities. 
Antiobesity and tobacco-cessation medications have yet to 
be added to the national formulary and can be obtained 
only  through  private-sector  pharmacies  at  appreciably 
higher costs.
Two of the major risk factors propelling the current epi-
demic of NCDs, namely tobacco and obesity, can be curbed 
through implementation of appropriate strategies, such as 
the WHO Global Strategy on Diet, Physical Activity, and 
Health (35). Furthermore, the call by Strong et al (2), to 
set a target to reduce deaths from chronic diseases by an 
annual rate of 2% deserves due consideration and integra-
tion into Oman’s national health goals.
Decision  makers  and  health  planners  need  to  have 
greater political commitment to the provision of services 
for  people  with  chronic  diseases.  Commitment  is  most 
likely  to  be  forthcoming  if  more  evidence  is  produced 
nationally demonstrating the increasing burden of NCDs. 
Greater commitment to providing chronic disease services 
will  result  from  national  research  and  from  continuous 
dialogue between advocates of chronic disease control and 
policy makers. Greater emphasis on health promotion will 
enable people, both the chronically ill and the healthy, to 
increase control over their health and to improve it.
Finally, various departments of the government make 
polices and decisions that inevitably have an impact on 
major risk factors and, ultimately, on the health of the 
nation. However, collaboration and joint planning among 
government  sections  are  still  rudimentary  and  need  to 
be strengthened through development of a national plan-
ning framework under the leadership of the Ministry of 
National  Economy.  Preventive  health  programs  would 
have better outcomes if public polices on taxation, trade, 
food, urban planning, and the like are evidence-based and 
set with due consideration of public health.
Oman faces an epidemic of chronic NCDs. Oman’s rapid 
socioeconomic  development  coupled  with  demographic 
trends over the past 37 years reflects positively on Oman’s 
health  indicators,  most  notably  on  the  increase  in  life 
expectancy at birth. However, such achievements may be 
overshadowed  by  the  dramatic  rise  of  chronic  diseases, 
including cardiovascular disease, diabetes and other obesi-
ty-associated syndromes, chronic renal failure, and cancer, 
which are costly to treat. If the achievements in the health 
of the nation accomplished over the past 4 decades are to 
continue, there must be concerted efforts and coordinated 
policies on the part of government with greater emphasis 
on proven, cost-effective primary prevention services that 
focus on lifestyle and behavior change.
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Tables
Table. Estimated Changes in Per Capita Imports of Selected Food Products and Cigarettes, Oman, 1993 and 2003a
Commodity 1993 (Metric Tons) 2003 (Metric Tons) % Change
Chicken 7.2 27. +59%
Dry whole cow milk 5.2 8. +28%
Wheat 77.6 82.7 +7%
Oranges 6.9 7. +%
Whole milk (evaporated) 6.8 0.9 +60%
Sugar (refined) 6.7 2.8 +9%
Palm oil .7 0.7 −9%
Sheep milk cheese 2. 3. +62%
Chocolate products 2.0 2.5 +25%
Cigarettes 5.9 7. +25%
 
a Data are from the United Nations (25).